Inhibition of SREBP2 reduces cellular cholesterol levels and suppresses ZIKV infection, whereas ABCG1 deficiency enhances lipid droplet accumulation and promotes ZIKV replication, suggesting that ABCG1 limits intracellular cholesterol availability for viral exploitation. This evidence concerns the gene SREBF2 and Zika virus infectious disease.